Reinforcing transplantation with consolidation therapy in Hodgkin lymphoma
Can ibrutinib be used as a first-line treatment in CLL?
Key questions to be discussed at iwCLL 2017: cancer genetics, immunology and categorizing patients
Real world data of ixazomib in combination with lenalidomide and dexamethasome
The importance of venetoclax in treating CLL